Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Duexis (Ibuprofen/Famotidine) Follow-On Study
NCT00613106Phase 3Completed
- Sponsor
- Amgen
- Start
- Sep 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen + famotidine in osteoarthritis (OA), rheumatoid arthritis (RA), chronic low back pain (CLBP), complex regional pain syndrome (CRPS), chronic myofascial pain (CMP), sponsored by Amgen. Started Sep 2007; status: completed.
02
Drugs
ibuprofen + famotidine
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)chronic low back pain (CLBP)complex regional pain syndrome (CRPS)chronic myofascial pain (CMP)
Beyond the preview
Go deeper on NCT00613106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00613106.